Similarly a genetic risk score including variants in PNPLA3, TM6SF2, HSD17B13 and GCKR found a significant association with steatosis, steatohepatitis and fibrosis in a large cohort of patients with histologically characterized NAFLD [53••]. The gene discussed is PNPLA3; the disease is metabolic dysfunction-associated steatotic liver disease.